China NMPA Drug Inspection - Ordos Mongolian Medicine Research Institute, Inner Mongolia Autonomous Region - Erdun-Urile (two parties)
China NMPA drug inspection for Ordos Mongolian Medicine Research Institute, Inner Mongolia Autonomous Region published March 02, 2017. Drug: Erdun-Urile (two parties). The Inner Mongolia Food and Drug Administration announced the results of its 2016 drug quality sampling inspections on M
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Ordos Mongolian Medicine Research Institute, Inner Mongolia Autonomous Region published March 02, 2017. Drug: Erdun-Urile (two parties). The Inner Mongolia Food and Drug Administration announced the results of its 2016 drug quality sampling inspections on M
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox